RXRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.43%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,163,426.48

Recursion Pharmaceuticals Insider Trading History Chart

Recursion Pharmaceuticals Share Price & Price History

^$4.92

▲ +0.26 (5.58%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Recursion Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/2/2025	Blake Borgeson	Director	Sell	220,000	$4.37	$961,400.00	6,869,863
8/18/2025	Najat Khan	Insider	Sell	36,599	$5.52	$202,026.48	668,197
11/13/2024	Michael Secora	CFO	Sell	15,000	$7.66	$114,900.00	1,499,631
11/12/2024	Blake Borgeson	Director	Sell	11,447	$7.64	$87,455.08	7,066,113
10/29/2024	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,077,560
10/24/2024	Tina Marriott	COO	Sell	6,000	$6.31	$37,860.00	521,138
10/15/2024	Blake Borgeson	Director	Sell	11,447	$6.67	$76,351.49	7,089,007
10/8/2024	Michael Secora	CFO	Sell	15,000	$6.32	$94,800.00	1,426,506
10/2/2024	Christopher Gibson	CEO	Sell	20,000	$6.16	$123,200.00	762,656
10/1/2024	Blake Borgeson	Director	Sell	11,447	$6.22	$71,200.34	7,098,428
9/26/2024	Tina Marriott	COO	Sell	6,000	$7.00	$42,000.00	521,138
9/17/2024	Blake Borgeson	Director	Sell	11,447	$6.84	$78,297.48	7,109,875
9/10/2024	Michael Secora	CFO	Sell	15,000	$6.17	$92,550.00	1,377,756
9/4/2024	Christopher Gibson	CEO	Sell	20,000	$6.04	$120,800.00	762,656
9/3/2024	Blake Borgeson	Director	Sell	11,447	$6.27	$71,772.69	7,121,322
8/29/2024	Tina Marriott	COO	Sell	6,000	$7.56	$45,360.00	521,138
8/20/2024	Blake Borgeson	Director	Sell	11,447	$7.12	$81,502.64	7,132,769
8/13/2024	Michael Secora	CFO	Sell	15,000	$6.35	$95,250.00	1,340,968
8/7/2024	Christopher Gibson	CEO	Sell	30,000	$7.10	$213,000.00	758,738
8/6/2024	Blake Borgeson	Director	Sell	11,447	$6.82	$78,068.54	7,144,216
7/25/2024	Tina Marriott	COO	Sell	6,000	$8.13	$48,780.00	535,457
7/23/2024	Blake Borgeson	Director	Sell	11,447	$8.48	$97,070.56	7,155,663
7/10/2024	Christopher Gibson	CEO	Sell	50,000	$7.48	$374,000.00	758,738
7/9/2024	Blake Borgeson	Director	Sell	11,447	$7.32	$83,792.04	7,167,110
7/9/2024	Michael Secora	CFO	Sell	15,000	$7.32	$109,800.00	1,292,218
6/27/2024	Tina Marriott	COO	Sell	6,000	$7.21	$43,260.00	535,457
6/25/2024	Blake Borgeson	Director	Sell	11,447	$9.51	$108,860.97	7,177,116
6/13/2024	Michael Secora	CFO	Sell	15,000	$9.32	$139,800.00	1,243,468
6/11/2024	Blake Borgeson	Director	Sell	11,447	$8.45	$96,727.15	7,188,563
6/5/2024	Christopher Gibson	CEO	Sell	50,000	$8.42	$421,000.00	758,738
5/30/2024	Tina Marriott	COO	Sell	3,000	$8.78	$26,340.00	535,457
5/28/2024	Blake Borgeson	Director	Sell	11,447	$9.17	$104,968.99	7,186,913
5/1/2024	Christopher Gibson	CEO	Sell	50,000	$7.73	$386,500.00	863,524
4/30/2024	Blake Borgeson	Director	Sell	11,447	$7.95	$91,003.65	7,218,414
4/25/2024	Tina Marriott	COO	Sell	3,000	$7.67	$23,010.00	543,231
4/17/2024	Michael Secora	CFO	Sell	23,124	$7.58	$175,279.92	1,231,055
4/16/2024	Blake Borgeson	Director	Sell	11,447	$7.66	$87,684.02	7,229,861
4/3/2024	Christopher Gibson	CEO	Sell	40,000	$8.84	$353,600.00	978,524
4/2/2024	Blake Borgeson	Director	Sell	11,447	$8.82	$100,962.54	7,241,308
3/28/2024	Christopher Gibson	CEO	Sell	40,000	$10.10	$404,000.00	1,043,524
3/21/2024	Tina Marriott	COO	Sell	8,000	$10.75	$86,000.00	639,982
3/19/2024	Blake Borgeson	Director	Sell	20,054	$10.79	$216,382.66	7,252,755
3/13/2024	Michael Secora	CFO	Sell	25,000	$11.03	$275,750.00	1,204,179
3/6/2024	Christopher Gibson	CEO	Sell	36,319	$11.86	$430,743.34	1,108,524
3/5/2024	Blake Borgeson	Director	Sell	20,054	$12.06	$241,851.24	7,272,809
2/22/2024	Tina Marriott	COO	Sell	8,000	$14.89	$119,120.00	639,982
2/20/2024	Blake Borgeson	Director	Sell	20,054	$12.32	$247,065.28	7,292,863
2/13/2024	Michael Secora	CFO	Sell	25,000	$9.86	$246,500.00	1,173,851
2/7/2024	Christopher Gibson	CEO	Sell	48,272	$9.22	$445,067.84	774,703
2/6/2024	Blake Borgeson	Director	Sell	11,447	$9.30	$106,457.10	7,312,917
1/25/2024	Tina Marriott Larson	COO	Sell	8,000	$10.35	$82,800.00	414,548
1/23/2024	Blake Borgeson	Director	Sell	20,054	$10.58	$212,171.32	7,324,364
1/16/2024	Michael Secora	CFO	Sell	25,000	$10.45	$261,250.00	968,514
1/16/2024	Shafique Virani	Insider	Sell	18,000	$10.93	$196,740.00	136,748
1/9/2024	Dean Y. Li	Director	Sell	29,000	$13.66	$396,140.00	421,000
1/3/2024	Christopher Gibson	CEO	Sell	30,853	$9.49	$292,794.97	791,725
12/26/2023	Blake Borgeson	Director	Sell	20,054	$10.63	$213,174.02	7,364,472
12/15/2023	Shafique Virani	Insider	Sell	18,000	$9.60	$172,800.00	136,748
12/14/2023	Zavain Dar	Director	Sell	20,141	$9.00	$181,269.00	53,823
12/12/2023	Blake Borgeson	Director	Sell	11,447	$7.40	$84,707.80	7,384,526
12/12/2023	Michael Secora	CFO	Sell	25,000	$7.39	$184,750.00	943,514
12/6/2023	Christopher Gibson	CEO	Sell	59,829	$7.49	$448,119.21	791,328
11/28/2023	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,395,973
11/16/2023	Tina Marriott Larson	COO	Sell	3,000	$6.76	$20,280.00	413,404
11/15/2023	Shafique Virani	Insider	Sell	18,000	$6.51	$117,180.00	140,351
11/14/2023	Blake Borgeson	Director	Sell	8,885	$6.32	$56,153.20	7,407,420
11/14/2023	Michael Secora	CFO	Sell	25,000	$6.32	$158,000.00	925,686
11/1/2023	Christopher Gibson	CEO	Sell	37,177	$5.20	$193,320.40	836,820
10/31/2023	Blake Borgeson	Director	Sell	8,885	$5.27	$46,823.95	7,416,305
10/26/2023	Tina Marriott Larson	COO	Sell	3,000	$5.63	$16,890.00	418,782
10/17/2023	Blake Borgeson	Director	Sell	8,885	$6.58	$58,463.30	7,425,190
10/16/2023	Shafique Virani	Insider	Sell	18,000	$6.30	$113,400.00	140,351
10/10/2023	Michael Secora	CFO	Sell	25,000	$7.07	$176,750.00	900,686
10/4/2023	Christopher Gibson	CEO	Sell	59,794	$7.21	$431,114.74	842,747
10/3/2023	Blake Borgeson	Director	Sell	8,885	$7.29	$64,771.65	7,434,075
9/28/2023	Tina Marriott Larson	COO	Sell	3,000	$7.72	$23,160.00	418,782
9/19/2023	Blake Borgeson	Director	Sell	8,885	$8.36	$74,278.60	7,442,960
9/15/2023	Shafique Virani	Insider	Sell	18,000	$8.66	$155,880.00	140,351
9/13/2023	Michael Secora	CFO	Sell	25,000	$8.69	$217,250.00	888,186
9/6/2023	Christopher Gibson	CEO	Sell	33,765	$8.78	$296,456.70	871,291
9/5/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,451,845
8/24/2023	Tina Marriott Larson	COO	Sell	3,000	$8.66	$25,980.00	418,782
8/22/2023	Blake Borgeson	Director	Sell	8,885	$8.91	$79,165.35	7,460,730
8/16/2023	Michael Secora	CFO	Sell	25,000	$8.90	$222,500.00	863,186
8/15/2023	Shafique Virani	Insider	Sell	18,000	$9.25	$166,500.00	140,351
8/8/2023	Blake Borgeson	Director	Sell	17,770	$11.16	$198,313.20	7,469,615
8/2/2023	Christopher Gibson	CEO	Sell	65,015	$13.04	$847,795.60	890,719
7/27/2023	Tina Marriott Larson	COO	Sell	8,000	$13.62	$108,960.00	424,160
7/26/2023	Shafique Virani	Insider	Sell	20,000	$14.41	$288,200.00	143,954
7/25/2023	Blake Borgeson	Director	Sell	18,719	$14.61	$273,484.59	7,487,385
7/18/2023	Michael Secora	CFO	Sell	25,000	$13.63	$340,750.00	830,413
7/17/2023	Shafique Virani	Insider	Sell	30,000	$11.72	$351,600.00	143,954
7/13/2023	Terry-Ann Burrell	Director	Sell	8,275	$12.59	$104,182.25	54,847
7/12/2023	Christopher Gibson	CEO	Sell	31,818	$13.14	$418,088.52	915,810
7/11/2023	Blake Borgeson	Director	Sell	8,885	$6.89	$61,217.65	7,520,104
6/29/2023	Tina Marriott Larson	COO	Sell	3,000	$7.49	$22,470.00	424,160
6/27/2023	Blake Borgeson	Director	Sell	8,885	$7.39	$65,660.15	7,528,989
6/13/2023	Blake Borgeson	Director	Sell	15,485	$9.98	$154,540.30	7,525,262
6/13/2023	Michael Secora	CFO	Sell	25,000	$9.93	$248,250.00	805,413
6/7/2023	Christopher Gibson	CEO	Sell	56,436	$9.05	$510,745.80	916,378
6/1/2023	Shafique Virani	Insider	Sell	25,000	$8.58	$214,500.00	161,819
5/31/2023	Tina Marriott Larson	COO	Sell	3,000	$8.63	$25,890.00	424,160
5/30/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,540,747
5/16/2023	Blake Borgeson	Director	Sell	8,885	$5.09	$45,224.65	7,549,632
5/3/2023	Christopher Gibson	CEO	Sell	33,073	$4.71	$155,773.83	953,225
4/18/2023	Blake Borgeson	Director	Sell	8,885	$5.93	$52,688.05	7,558,517
4/5/2023	Christopher Gibson	CEO	Sell	13,327	$6.46	$86,092.42	946,710
4/4/2023	Blake Borgeson	Director	Sell	8,885	$6.53	$58,019.05	7,567,402
3/21/2023	Blake Borgeson	Director	Sell	8,885	$7.40	$65,749.00	7,576,287
3/8/2023	Christopher Gibson	CEO	Sell	70,890	$8.10	$574,209.00	963,787
3/7/2023	Blake Borgeson	Director	Sell	8,885	$8.33	$74,012.05	7,585,172
3/2/2023	Christopher Gibson	CEO	Sell	18,500	$7.92	$146,520.00	940,927
2/27/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	52,500	$7.69	$403,725.00	12,869,423
2/23/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	51,864	$7.79	$404,020.56	12,707,805
2/23/2023	Tina Marriott Larson	COO	Sell	8,000	$7.82	$62,560.00	427,844
2/21/2023	Blake Borgeson	Director	Sell	8,885	$7.73	$68,681.05	7,594,057
2/21/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	94,418	$7.74	$730,795.32	12,605,000
2/16/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	42,682	$7.90	$337,187.80	12,447,200
2/15/2023	Shafique Virani	Insider	Sell	7,486	$8.33	$62,358.38	189,846
2/14/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	6,300	$7.95	$50,085.00	12,404,518
2/10/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	11,000	$7.98	$87,780.00	12,365,744
2/7/2023	Blake Borgeson	Director	Sell	8,885	$8.81	$78,276.85	7,602,942
1/26/2023	Tina Marriott Larson	COO	Sell	8,000	$8.07	$64,560.00	203,654
1/25/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	24,526	$7.88	$193,264.88	12,346,258
1/24/2023	Blake Borgeson	Director	Sell	8,885	$8.71	$77,388.35	7,611,827
1/17/2023	Shafique Virani	Insider	Sell	10,000	$9.16	$91,600.00	73,160
1/10/2023	Blake Borgeson	Director	Sell	8,885	$7.69	$68,325.65	7,620,712
1/9/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	76,046	$7.64	$580,991.44	12,252,214
1/5/2023	Christopher Gibson	CEO	Sell	18,500	$7.39	$136,715.00	525,805
1/5/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	80,035	$7.38	$590,658.30	12,107,215
1/3/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	141,646	$7.50	$1,062,345.00	11,935,288
12/29/2022	Tina Marriott Larson	COO	Sell	8,000	$7.70	$61,600.00	203,654
12/27/2022	Blake Borgeson	Director	Sell	8,885	$7.25	$64,416.25	7,628,272
12/15/2022	Shafique Virani	Insider	Sell	10,000	$8.85	$88,500.00	78,160
12/13/2022	Blake Borgeson	Director	Sell	8,885	$8.96	$79,609.60	7,637,157

SEC Filings (Institutional Ownership Changes) for Recursion Pharmaceuticals (NASDAQ:RXRX)

89.06% of Recursion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Recursion Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/2/2025	Allworth Financial LP	9,548	$47K	0.0%	+85.6%	0.002%
12/2/2025	IFP Advisors Inc	10,355	$51K	0.0%	+81.5%	0.002%
12/2/2025	Swiss Life Asset Management Ltd	13,393	$65K	0.0%	N/A	0.003%
11/21/2025	CIBC Bancorp USA Inc.	39,098	$0.19M	0.0%	N/A	0.008%
11/19/2025	Caitong International Asset Management Co. Ltd	18,659	$91K	0.1%	+106.9%	0.004%
11/17/2025	NewEdge Advisors LLC	13,531	$66K	0.0%	+22.3%	0.003%
11/17/2025	Dark Forest Capital Management LP	33,397	$0.16M	0.0%	N/A	0.006%
11/17/2025	Verity Asset Management Inc.	99,337	$0.49M	0.2%	N/A	0.019%
11/17/2025	Scientech Research LLC	13,426	$66K	0.0%	-89.6%	0.003%
11/17/2025	Sherbrooke Park Advisers LLC	29,684	$0.15M	0.1%	+161.4%	0.006%
11/17/2025	Mariner LLC	93,581	$0.46M	0.0%	+6.0%	0.018%
11/17/2025	Moors & Cabot Inc.	28,646	$0.14M	0.0%	-35.7%	0.006%
11/17/2025	Mercer Global Advisors Inc. ADV	16,085	$78K	0.0%	-44.2%	0.003%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	208,760	$1.02M	0.0%	+2.6%	0.040%
11/17/2025	Focus Partners Wealth	18,555	$91K	0.0%	+29.4%	0.004%
11/17/2025	Brevan Howard Capital Management LP	30,159	$0.15M	0.0%	-73.4%	0.006%
11/17/2025	Ameriprise Financial Inc.	45,871	$0.22M	0.0%	-8.3%	0.009%
11/14/2025	Lazard Asset Management LLC	495,164	$2.42M	0.0%	+22.5%	0.114%
11/14/2025	Raymond James Financial Inc.	115,460	$0.56M	0.0%	-2.4%	0.027%
11/14/2025	Equitable Holdings Inc.	39,400	$0.19M	0.0%	+7.1%	0.009%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	113,650	$0.56M	0.0%	+31.4%	0.026%
11/14/2025	Shay Capital LLC	48,311	$0.24M	0.0%	N/A	0.011%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	4,196,978	$20.48M	0.0%	-9.1%	0.967%
11/14/2025	Tower Research Capital LLC TRC	161,671	$0.79M	0.0%	+109.5%	0.037%
11/14/2025	Two Sigma Investments LP	2,450,805	$11.96M	0.0%	+109.9%	0.565%
11/14/2025	Nan Fung Group Holdings Ltd	595,287	$2.91M	4.9%	-10.4%	0.137%
11/13/2025	Jump Financial LLC	555,078	$2.71M	0.0%	-51.8%	0.128%
11/13/2025	Sei Investments Co.	50,525	$0.25M	0.0%	+167.9%	0.012%
11/13/2025	Capital Fund Management S.A.	726,024	$3.54M	0.0%	+0.8%	0.167%
11/13/2025	Mackenzie Financial Corp	21,940	$0.11M	0.0%	+35.6%	0.005%
11/13/2025	Franklin Resources Inc.	96,146	$0.47M	0.0%	+15.2%	0.022%
11/13/2025	Legal & General Group Plc	353,608	$1.73M	0.0%	+12.3%	0.081%
11/13/2025	Swiss National Bank	620,600	$3.03M	0.0%	+9.6%	0.143%
11/13/2025	Russell Investments Group Ltd.	48,033	$0.23M	0.0%	+345.5%	0.011%
11/13/2025	Private Advisor Group LLC	53,023	$0.26M	0.0%	-32.8%	0.012%
11/13/2025	Powell Investment Advisors LLC	11,607	$57K	0.0%	-42.1%	0.003%
11/13/2025	First Trust Advisors LP	1,797,205	$8.77M	0.0%	-4.4%	0.414%
11/12/2025	Barclays PLC	1,550,226	$7.57M	0.0%	+33.1%	0.357%
11/12/2025	Amova Asset Management Americas Inc.	7,465,858	$36.36M	0.4%	-8.6%	1.720%
11/12/2025	ARK Investment Management LLC	33,545,499	$163.70M	1.0%	+1.7%	7.727%
11/12/2025	Cresset Asset Management LLC	39,416	$0.19M	0.0%	+61.8%	0.009%
11/12/2025	Kingsview Wealth Management LLC	32,578	$0.16M	0.0%	-68.3%	0.008%
11/12/2025	Arete Wealth Advisors LLC	39,544	$0.19M	0.0%	-56.3%	0.009%
11/12/2025	Rafferty Asset Management LLC	750,191	$3.66M	0.0%	+110.6%	0.173%
11/12/2025	Quantbot Technologies LP	12,444	$61K	0.0%	N/A	0.003%
11/12/2025	R Squared Ltd	35,396	$0.17M	0.1%	-42.2%	0.008%
11/12/2025	Xponance Inc.	30,020	$0.15M	0.0%	+8.0%	0.007%
11/12/2025	Integrated Advisors Network LLC	37,632	$0.18M	0.0%	+82.7%	0.009%
11/12/2025	DNB Asset Management AS	313,707	$1.53M	0.0%	N/A	0.072%
11/12/2025	Total Clarity Wealth Management Inc.	31,600	$0.15M	0.0%	N/A	0.007%
11/12/2025	Intech Investment Management LLC	159,253	$0.78M	0.0%	-17.6%	0.037%
11/10/2025	Ameritas Investment Partners Inc.	30,643	$0.15M	0.0%	-11.6%	0.007%
11/10/2025	Vestmark Advisory Solutions Inc.	621,059	$3.03M	0.1%	-53.6%	0.143%
11/10/2025	Rossby Financial LCC	43,000	$0.22M	0.1%	+53.6%	0.010%
11/10/2025	Raiffeisen Bank International AG	140,000	$0.69M	0.0%	+7.7%	0.032%
11/10/2025	China Universal Asset Management Co. Ltd.	74,902	$0.37M	0.0%	-6.7%	0.017%
11/10/2025	Clear Creek Financial Management LLC	122,787	$0.60M	0.1%	+423.8%	0.028%
11/7/2025	Axxcess Wealth Management LLC	30,800	$0.15M	0.0%	-24.6%	0.007%
11/7/2025	Vanguard Group Inc.	39,780,153	$194.13M	0.0%	+10.3%	9.163%
11/7/2025	JPMorgan Chase & Co.	419,618	$2.05M	0.0%	+5.0%	0.097%
11/6/2025	Onyx Bridge Wealth Group LLC	17,500	$85K	0.0%	+52.2%	0.004%
11/6/2025	Cibc World Market Inc.	56,531	$0.28M	0.0%	+37.8%	0.013%
11/6/2025	Rhumbline Advisers	520,785	$2.54M	0.0%	+0.7%	0.120%
11/6/2025	Stratos Wealth Partners LTD.	110,611	$0.54M	0.0%	+12.1%	0.025%
11/6/2025	Wealthfront Advisers LLC	11,586	$57K	0.0%	N/A	0.003%
11/6/2025	Profund Advisors LLC	161,455	$0.79M	0.0%	+109.6%	0.037%
11/6/2025	ProShare Advisors LLC	77,939	$0.38M	0.0%	-7.8%	0.018%
11/5/2025	Prime Capital Investment Advisors LLC	27,403	$0.13M	0.0%	-9.7%	0.006%
11/5/2025	IQ EQ FUND MANAGEMENT IRELAND Ltd	1,774,995	$8.66M	0.6%	+94.8%	0.409%
11/5/2025	SBI Securities Co. Ltd.	128,114	$0.63M	0.0%	+2.5%	0.030%
11/5/2025	Savant Capital LLC	10,971	$54K	0.0%	N/A	0.003%
11/5/2025	Envestnet Asset Management Inc.	175,115	$0.86M	0.0%	-7.8%	0.040%
11/5/2025	Cherry Creek Investment Advisors Inc.	66,781	$0.33M	0.1%	+4.1%	0.015%
11/4/2025	Buck Wealth Strategies LLC	15,327	$75K	0.0%	N/A	0.004%
11/4/2025	Jones Financial Companies Lllp	34,318	$0.16M	0.0%	-51.3%	0.008%
11/4/2025	Principal Financial Group Inc.	28,072	$0.14M	0.0%	+16.2%	0.006%
11/4/2025	Nan Fung Trinity HK Ltd.	69,323	$0.34M	0.0%	N/A	0.016%
11/3/2025	Arizona State Retirement System	94,545	$0.46M	0.0%	+9.4%	0.022%
10/31/2025	Pier 88 Investment Partners LLC	118,560	$0.58M	0.1%	+59.1%	0.027%
10/31/2025	PFG Investments LLC	10,800	$53K	0.0%	N/A	0.002%
10/31/2025	Baillie Gifford & Co.	23,978,695	$117.02M	0.1%	-0.8%	5.523%
10/30/2025	Universal Beteiligungs und Servicegesellschaft mbH	229,617	$1.12M	0.0%	N/A	0.053%
10/29/2025	Arkadios Wealth Advisors	45,452	$0.22M	0.0%	-6.6%	0.010%
10/29/2025	Wealth Enhancement Advisory Services LLC	19,096	$100K	0.0%	+75.0%	0.004%
10/27/2025	Sumitomo Mitsui Trust Group Inc.	7,465,858	$36.43M	0.0%	-8.6%	1.720%
10/23/2025	Nisa Investment Advisors LLC	61,258	$0.30M	0.0%	+1,505.7%	0.014%
10/23/2025	Benjamin Edwards Inc.	143,164	$0.70M	0.0%	-13.1%	0.033%
10/23/2025	SG Americas Securities LLC	14,701	$72K	0.0%	-90.5%	0.003%
10/23/2025	JTC Employer Solutions Trustee Ltd	14,317	$70K	0.0%	+498.5%	0.003%
10/23/2025	KLP Kapitalforvaltning AS	73,000	$0.36M	0.0%	+19.3%	0.017%
10/21/2025	Ascent Wealth Partners LLC	21,771	$0.11M	0.0%	+24.4%	0.005%
10/21/2025	Global Retirement Partners LLC	50,545	$0.25M	0.0%	+64.1%	0.012%
10/21/2025	Values First Advisors Inc.	89,215	$0.44M	0.2%	-1.9%	0.021%
10/21/2025	Bank Pictet & Cie Europe AG	1,630,000	$7.95M	0.2%	N/A	0.375%
10/20/2025	LVW Advisors LLC	13,000	$63K	0.0%	N/A	0.003%
10/20/2025	Kieckhefer Group LLC	74,000	$0.36M	0.2%	+94.7%	0.017%
10/17/2025	Sowell Financial Services LLC	54,667	$0.27M	0.0%	N/A	0.013%
10/16/2025	180 Wealth Advisors LLC	56,230	$0.27M	0.0%	+42.6%	0.013%
10/15/2025	CWM LLC	14,605	$71K	0.0%	+23.6%	0.003%
10/15/2025	Green Alpha Advisors LLC	212,202	$1.04M	1.0%	+21.2%	0.049%

Data available starting January 2016

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $4.92

$4.58

$4.94

50 Day Range

MA: $5.13

$3.85

$6.79

52 Week Range

Now: $4.92

$3.79

$12.36

Volume

19,790,251 shs

Average Volume

24,891,348 shs

Market Capitalization

$2.56 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top insider investors include:
Blake Borgeson (Director)
Michael Secora (CFO)
Christopher Gibson (CEO)
Najat Khan (Insider)
Tina Marriott (COO)
Dean Y Li (Director)
Tina Marriott Larson (COO)
Shafique Virani (Insider)
Zavain Dar (Director)
Learn More about top insider investors at Recursion Pharmaceuticals.
Who are the major institutional investors of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 9.16%
ARK Investment Management LLC — 7.73%
Baillie Gifford & Co. — 5.52%
Sumitomo Mitsui Trust Group Inc. — 1.72%
Amova Asset Management Americas Inc. — 1.72%
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC — 0.97%
Learn More about top institutional investors of Recursion Pharmaceuticals stock.
Which institutional investors are selling Recursion Pharmaceuticals stock?: Within the previous quarter, RXRX stock was sold by these institutional investors:
Caption Management LLC
Vestmark Advisory Solutions Inc.
Sumitomo Mitsui Trust Group Inc.
Amova Asset Management Americas Inc.
Jump Financial LLC
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC
Baillie Gifford & Co.
Group One Trading LLC
Which institutional investors are buying Recursion Pharmaceuticals stock?: During the previous quarter, RXRX stock was acquired by institutional investors including:
Vanguard Group Inc.
Bank Pictet & Cie Europe AG
Two Sigma Investments LP
IQ EQ FUND MANAGEMENT IRELAND Ltd
ARK Investment Management LLC
Susquehanna International Group LLP
Rafferty Asset Management LLC
Citadel Advisors LLC